|
HTR7P1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.271400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.082430E-01 |
| Normal-vs-Stage2 |
4.719600E-01 |
| Normal-vs-Stage3 |
9.725800E-01 |
| Normal-vs-Stage4 |
1.474230E-01 |
| Stage1-vs-Stage2 |
6.585000E-01 |
| Stage1-vs-Stage3 |
2.737600E-01 |
| Stage1-vs-Stage4 |
4.768400E-01 |
| Stage2-vs-Stage3 |
5.751000E-01 |
| Stage2-vs-Stage4 |
4.625600E-01 |
| Stage3-vs-Stage4 |
2.917800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.076400E-01 |
| Normal-vs-AfricanAmerican |
1.109630E-01 |
| Normal-vs-Asian |
1.074560E-01 |
| Caucasian-vs-AfricanAmerican |
1.450390E-01 |
| Caucasian-vs-Asian |
2.660200E-01 |
| AfricanAmerican-vs-Asian |
5.125800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.933600E-01 |
| Normal-vs-Female |
4.777200E-01 |
| Male-vs-Female |
7.193400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.744100E-02 |
| Normal-vs-Extreme_Weight |
4.424200E-01 |
| Normal-vs-Obese |
8.130800E-01 |
| Normal-vs-Extreme_Obese |
5.997800E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.774600E-01 |
| Normal_Weight-vs-Obese |
1.086240E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.403800E-01 |
| Extreme_Weight-vs-Obese |
5.963200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.977000E-01 |
| Obese-vs-Extreme_Obese |
1.649820E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.754800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.765400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.575400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.224300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.115200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.659600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.825600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.438600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.058440E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.554400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.114200E-01 |
| Normal-VS-Type2 PRCC |
1.979550E-03 |
| Normal-VS-KIRP CIMP |
7.078000E-01 |
| Normal-VS-Unclassified PRCC |
7.054800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.65570000004922E-06 |
| Type1 PRCC-VS-KIRP CIMP |
7.301000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.433600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.455960E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.573800E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
8.222000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.082300E-02 |
| Normal-vs-N1 |
6.272400E-01 |
| Normal-vs-N2 |
8.104800E-01 |
| N0-vs-N1 |
2.665400E-01 |
| N0-vs-N2 |
5.296000E-01 |
| N1-vs-N2 |
9.750800E-01 |
|
|
